Healthcare News Round Up



world_stetIn our new battling for health site, I will be bringing you news round up from the healthcare industry every two weeks. Have a nice weekend!

Healthcare news

Lack of Insurance Harms Health, Requires Urgent National Action

A report from the Institute of Medicine (IOM) urges the US government to urgently tackle the issue of health insurance coverage because evidence shows that lack of coverage has serious health consequences on the uninsured which can spill over to the whole community.

Legislation news

Tobacco Regulation: Is This the Year?

Advocates for tobacco regulation hope this is the year when the US FDA gets empowered to regulate sales and marketing of cigarettes and other tobacco products. The proposal have been opposed by the previous US administration but it seems that such a bill have a bigger chance under the new Democrat leadership.

Pharma industry news

Drug patent plan gets mixed reviews

GlaxoSmithKline (GSK), one of the world’s largest pharmaceutical companies made a generous offer to boost research and development into neglected diseases as well as collaborate with other companies on the issue. Neglected diseases are mainly tropical diseases such as sleeping sickness, visceral leishmaniasis, and dengue fever that are seldom on the priority list of pharma companies. The offer was made by GSK CEO Andrew Witty in a speech at Harvard Medical School last month.

The aim would be to foster a global public-private network to supplant the present fragmented research efforts on the most neglected diseases…” Witty’s announcement triggered mixed reactions from scientists and public-health experts – “from wildly enthusiastic to deeply sceptical.” (Source: Nature News).

Falsified data gets India’s largest generic drug-maker into trouble

The US FDA penalized one of the world’s largest manufacturer of generic drugs. Ranbaxy Laboratories is India’s biggest drugmaker and was caught falsifying data in one of its manufacturing facilities. The consequences of the penalty “revokes 25 existing approvals of drugs made at its factory at Paonta Sahib in Himachal Pradesh, and stops an unnamed number of pending applications for drugs that rely on data from the same plant.”

Events

Online Health Chats with Cleveland Clinic Experts

  • A Q&A with Dr. Nissen
    Wednesday, March 11, 2009 – 12 noon (EST)
    Dr. Steven Nissen is the Chairman of the Department of Cardiology at Cleveland Clinic and will answer your questions on the current state of cardiovascular care.
  • Hypertension & Your Kidneys
    Monday, March 16, 2009 – 12 noon (EST)
    One in four Americans are hypertensive and poorly controlled hypertension is a major cause of cardiovascular and kidney disease. Dr. Mohammed Rafey, a Cleveland Clinic specialist on Nephrology and Hypertension will answer your question on this topic.
  • Epilepsy in Children and Adolescents: Treatment & Care
    Thursday, March 26, 2009 – 12 noon (EST)
    More than 2.7 million Americans have epilepsy, many of them children. Dr. Ingrid Tuxhorn of the Epilepsy Center will answer your questions on this disorder especially about epilepsy surgery.
Related Posts with Thumbnails
Print Friendly

Speak Your Mind

*


*

NOTE: The contents in this blog are for informational purposes only, and should not be construed as medical advice, diagnosis, treatment or a substitute for professional care. Always seek the advice of your physician or other qualified health professional before making changes to any existing treatment or program. Some of the information presented in this blog may already be out of date.
Read previous post:
Shaking off the winter blues (SAD!)

The groundhog was right earlier this month - winter in the northern hemisphere is taking longer than usual this year....

Close